Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.390
+0.330 (10.78%)
At close: Mar 9, 2026, 4:00 PM EDT
3.310
-0.080 (-2.36%)
After-hours: Mar 9, 2026, 7:52 PM EDT
Aclaris Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -64.92 | -132.07 | -88.48 | -86.91 | -90.87 | |
| Depreciation & Amortization | 0.45 | 0.81 | 0.86 | 0.8 | 0.92 | |
| Asset Writedown & Restructuring Costs | - | 86.91 | 6.63 | - | - | |
| Stock-Based Compensation | 12.38 | 10.86 | 20.54 | 15.04 | 14.06 | |
| Other Operating Activities | 2.3 | 2.5 | -27.27 | 4.7 | 25.09 | |
| Change in Accounts Receivable | 6.14 | -4.88 | 0.19 | 0.14 | 0.15 | |
| Change in Accounts Payable | 8.45 | -4.19 | -1.47 | 0.37 | 3.66 | |
| Change in Unearned Revenue | -3.82 | 23.93 | - | - | - | |
| Change in Other Net Operating Assets | -8.1 | -3.94 | 10.68 | -1.7 | -5.15 | |
| Operating Cash Flow | -47.11 | -20.08 | -78.33 | -67.57 | -52.13 | |
| Capital Expenditures | -0.11 | -0.12 | -1.31 | -0.61 | -0.31 | |
| Sale (Purchase) of Intangibles | -0.83 | -35.81 | - | - | - | |
| Investment in Securities | 49.31 | -33.84 | 47.53 | 13.23 | -167.32 | |
| Investing Cash Flow | 48.37 | -69.77 | 46.22 | 12.63 | -167.63 | |
| Long-Term Debt Repaid | - | - | - | - | -11.48 | |
| Net Debt Issued (Repaid) | - | - | - | - | -11.48 | |
| Issuance of Common Stock | - | 80.03 | 27.63 | 72.9 | 239.66 | |
| Repurchase of Common Stock | -0.45 | -0.41 | -0.1 | -0.03 | -3.12 | |
| Other Financing Activities | -5.42 | -5.09 | -0.83 | - | - | |
| Financing Cash Flow | -5.86 | 74.54 | 26.71 | 72.87 | 225.05 | |
| Net Cash Flow | -4.61 | -15.31 | -5.4 | 17.93 | 5.29 | |
| Free Cash Flow | -47.22 | -20.2 | -79.63 | -68.17 | -52.44 | |
| Free Cash Flow Margin | -603.42% | -107.89% | -254.84% | -229.13% | -775.65% | |
| Free Cash Flow Per Share | -0.39 | -0.26 | -1.14 | -1.04 | -0.92 | |
| Levered Free Cash Flow | -30.63 | -59.12 | -37.97 | -39.31 | -28.51 | |
| Unlevered Free Cash Flow | -30.63 | -59.12 | -37.97 | -39.31 | -28.51 | |
| Change in Working Capital | 2.67 | 10.92 | 9.39 | -1.2 | -1.34 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.